Case Study: GSK achieves portfolio clarity and growth with CLEAR

GSK grows digestive health share 4.3% with CLEAR

The customer GSK faced a significant challenge after merging its OTC healthcare business with Novartis into a $10.9bn joint venture. The newly formed portfolio had structural issues and unclear brand roles, creating a pressing need for a strategic partner. CLEAR was engaged to provide strategic guidance, leveraging its expertise in M&A transformation and consumer brand portfolios.

CLEAR implemented a data-driven approach to brand positioning and portfolio strategy, which included its Growth Map framework. This solution provided clarity, defined effective brand roles, and identified white space opportunities for growth. The results were substantial: GSK's Consumer Healthcare sales grew to £7.8 billion by 2017, with operating margins improving from 11.3% to 17.7%. Furthermore, the company's global share of the digestive health category grew by 4.3%, driven by the success of its innovation.

GSK